Sealed Therapeutic Shoe as Treatment of Diabetic Foot Ulcers
NCT ID: NCT04085926
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
4 participants
INTERVENTIONAL
2020-01-16
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this multicenter randomized controlled trial (RCT), 150 participants will be recruited and randomized to two treatment arms: TCC or sealed therapeutic shoe. The primary outcome is ulcer healing, secondary outcomes include (but are not limited to) skin complications, glycemic control, body mass index, gait function, balance, quality of life, physical activity, and health economics.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wound Healing: Total Contact Cast Vs. Custom-Made Temporary Footwear for Patients With Diabetic Foot Ulceration
NCT00304733
10 Years Follow-up Study of Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes
NCT04054076
Thickness-Varied Soft Surface on Shoe-Insoles Based on In-Shoe Pressure Measurement
NCT06679192
Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
NCT05236660
This Research Hypothesizes That the Use of a Rigid Rocker Sole Reduces the Recurrence Rate of Diabetic Foot Ulcers in Patients With Peripheral Neuropathy.
NCT02995863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants are randomized (blocked randomization, stratified for ulcer site and study center) to either treatment with a sealed therapeutic shoe or total contact cast.
Each participant will be assessed by a cast technician during the treatment period (for ulcer healing and skin complications) and be assessed by a physiotherapist on five occasions: at baseline, approximately 4 weeks into treatment and 1, 6 and 12 months after treatment end. On these occasions the physiotherapist will perform different tests (gait, balance, ankle strength and flexibility, bone mass density in heel bone, etc) and participants will answer questionnaires and have their physical activity measured for 7 days with an activity monitor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sealed shoe
Therapeutic footwear including off-the-shelf therapeutic shoes and custom-made insoles. The shoe on the ulcerated foot is "sealed", i.e., made irremovable, with a plastic band.
Sealed therapeutic shoe
Off-the-shelf therapeutic shoe and custom-made insole
Total contact cast
A irremovable custom-made total Contact cast enclosing the foot and shin
Total contact cast
Custom-made total contact cast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sealed therapeutic shoe
Off-the-shelf therapeutic shoe and custom-made insole
Total contact cast
Custom-made total contact cast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Foot ulcer under metatarsal heads
Exclusion Criteria
* critical ischemia (defined as toe pressure \<30 mmHg or TcPO2 \<30 mmHg)
* uncontrolled infection (IWGDF infection grade 4, or grade 3 if not treatment against infection has been administered)
* Active Charcot foot
* foot deformities that necessitate custom-made shoes
* inability to speak/read Swedish.
* People with increased risk that side-effects will not be discovered or reported (dementia, abuse of alcohol or drugs, intellectual disability, etc.) if the person do not have appropriate social support, will be excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forte
INDUSTRY
Region Örebro County
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gustav Jarl
Associate Professor, Certified Prosthetist and Orthotist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustav Jarl, PhD
Role: PRINCIPAL_INVESTIGATOR
University Health Care Research Center, Region Örebro county
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mölndahls sjukhus
Gothenburg, , Sweden
Skånes Universitetssjukhus, Malmö
Malmo, , Sweden
Örebro Universitetssjukhus
Örebro, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18RS6667
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.